Globus Medical, Inc. (GMED)

Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,511	2,519	1,568	1,023	958.1	789.04
Revenue Growth (YoY)	32.26%	60.62%	53.34%	6.76%	21.43%	0.47%
Cost of Revenue	827.56	819.88	476.52	262.83	239.22	217.46
Gross Profit	1,683	1,699	1,092	760.01	718.88	571.58
Selling, General & Admin	974.72	977.48	643.41	432.12	408.15	354.76
Research & Development	138.79	161.6	124.01	73.02	97.35	84.52
Operating Expenses	1,232	1,258	818.45	522.87	524.02	456.11
Operating Income	451.24	441.03	273.51	237.15	194.86	115.47
Interest Expense	-2.3	-4.19	-	-	-	-
Interest & Investment Income	1.68	-	20.13	14.23	9.3	13.95
Currency Exchange Gain (Loss)	-23.64	-43.29	14.26	-1.02	-1.42	-0.28
Other Non Operating Income (Expenses)	1.13	1.57	-1.35	7.24	3.36	1.38
EBT Excluding Unusual Items	428.11	395.12	306.55	257.6	206.09	130.53
Merger & Restructuring Charges	-195.93	-274.72	-139.93	-6.85	-16.98	-4.03
Gain (Loss) on Sale of Investments	1.08	0.64	-0.79	-5.39	-2.78	-0.59
Legal Settlements	-0.31	-0.31	-0.43	-2.34	-5.92	-0.01
Pretax Income	232.95	120.72	165.39	243.02	180.41	125.9
Income Tax Expense	47.39	17.74	42.52	52.85	31.22	23.61
Net Income	185.56	102.98	122.87	190.17	149.19	102.29
Net Income to Common	185.56	102.98	122.87	190.17	149.19	102.29
Net Income Growth	178.51%	-16.19%	-35.39%	27.47%	45.86%	-34.10%
Shares Outstanding (Basic)	136	136	113	100	101	99
Shares Outstanding (Diluted)	139	138	115	103	104	101
Shares Change (YoY)	13.05%	20.27%	11.68%	-0.95%	2.63%	-1.01%
EPS (Basic)	1.36	0.76	1.09	1.89	1.48	1.04
EPS (Diluted)	1.34	0.75	1.07	1.85	1.44	1.01
EPS Growth	145.70%	-29.91%	-42.16%	28.47%	42.57%	-33.55%
Free Cash Flow	522.59	405.21	165.23	104.42	219.38	135.14
Free Cash Flow Per Share	3.76	2.94	1.44	1.02	2.12	1.34
Gross Margin	67.04%	67.46%	69.62%	74.30%	75.03%	72.44%
Operating Margin	17.97%	17.51%	17.44%	23.18%	20.34%	14.63%
Profit Margin	7.39%	4.09%	7.83%	18.59%	15.57%	12.96%
Free Cash Flow Margin	20.81%	16.08%	10.53%	10.21%	22.90%	17.13%
EBITDA	716.01	695.05	418.24	305.4	264.73	178.35
EBITDA Margin	28.52%	27.59%	26.66%	29.86%	27.63%	22.60%
D&A For EBITDA	264.77	254.02	144.73	68.25	69.87	62.87
EBIT	451.24	441.03	273.51	237.15	194.86	115.47
EBIT Margin	17.97%	17.51%	17.44%	23.18%	20.34%	14.63%
Effective Tax Rate	20.34%	14.69%	25.71%	21.75%	17.30%	18.76%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q